Chinese stem cell therapy reverses heart failure in 90% of patients in landmark trial

A hospital in east China has used reprogrammed stem cells to treat severe heart failure, with 90 per cent of patients showing significant recovery in heart function after the novel therapy. On Wednesday, Nanjing Drum Tower Hospital, affiliated with Nanjing University, released the long-term follow-up results of a phase

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.